Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Viatrexx-GI

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-189-41 D-0339-2020
Class II · Moderate risk

Viatrexx-Mesenchyme

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-102-41 D-0338-2020
Class II · Moderate risk

Viatrexx-Lymph 1

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-310-41 D-0337-2020
Class II · Moderate risk

Viatrexx-Prolo

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-443-41 D-0336-2020
Class II · Moderate risk

Viatrexx-Collagen

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-095-41 D-0335-2020
Class II · Moderate risk

Viatrexx-Infla

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-249-41 D-0334-2020
Class II · Moderate risk

Viatrexx-Neuro 3

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-373-41 D-0333-2020
Class II · Moderate risk

Viatrexx-Articula

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-037-41 D-0332-2020
Class II · Moderate risk

Viatrexx-Systemic Detox

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-500-41 D-0331-2020
Class II · Moderate risk

Viatrexx-Adipose

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-024-41 D-0330-2020
Class II · Moderate risk

Viatrexx-Ithurts

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-270-41 D-0329-2020
Class II · Moderate risk

Viatrexx-Ouch

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-402-41 D-0328-2020
Class II · Moderate risk

Viatrexx-MuSkel-Neural

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-347-41 D-0327-2020
Class II · Moderate risk

Viatrexx-Connectissue

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-100-41 D-0326-2020
Class II · Moderate risk

PF-Fentanyl Citrate

GMP Deviations: potential glass contamination

Terminated cGMP deviation Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-0525-25 D-0147-2020
Class II · Moderate risk

Rifampin for Injection

Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.

Terminated Impurity / degradation Mylan Laboratories Limited (Sterile Products Division) NDC 67457-445-60 D-0139-2020

Recalls by year